Joanne Lynn Intile

855 Interim results from a comparative oncology safety study evaluating intravesical chitosan/interleukin-12 immunotherapy in client-owned dogs with invasive urothelial carcinoma

Helein, G. T., Nguyen, T. T., Intile, J. L., Mastromauro, M. L., Vaden, S. A., Hess, P. R., & Zaharoff, D. A. (2025, November 1). Regular and Young Investigator Award Abstracts, Vol. 11.

Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma

Chadsey, L. E., Hess, P. R., & Intile, J. L. (2025, November 6). Veterinary and Comparative Oncology.

Serum Symmetric Dimethylarginine as a Predictor of Toxicity of Carboplatin in Dogs

Gareau, A., Papich, M. G., Evans, B. J., & Intile, J. L. (2025, December 23). Veterinary and Comparative Oncology.

Novel genomic prognostic biomarkers for dogs with cancer

Chon, E., Sakthikumar, S., Tang, M., Hamilton, M. J., Vaughan, A., Smith, A., … Wang, G. (2023, October 7). Journal of Veterinary Internal Medicine, Vol. 10.

Discharge summaries provided to owners of pets newly diagnosed with cancer exceed recommended readability levels

Medland, J. E., Marks, S. L., & Intile, J. L. (2022, January 21). Journal of the American Veterinary Medical Association, Vol. 3.

Value, Limitations, and Recommendations for Grading of Canine Cutaneous Mast Cell Tumors: A Consensus of the Oncology-Pathology Working Group

Berlato, D., Bulman-Fleming, J., Clifford, C. A., Garrett, L., Intile, J., Jones, P., … Rasotto, R. (2021, April 23). Veterinary Pathology, Vol. 4.

Veterinary Clinical Ethics and Patient Care Dilemmas

Fogle, C., Intile, J., & Sheats, M. K. (2021, July 29). Veterinary Clinics of North America Small Animal Practice, Vol. 9.

Anal Sac

In E. Cote (Ed.), Clinical Veterinary Advisor: Dogs and Cats (4th ed.). Elsevier.

Evaluation of the Tolerability of Combination Chemotherapy with Mitoxantrone and Dacarbazine in Dogs with Lymphoma

Intile, J. L., Rassnick, K. M., Al-Sarraf, R., & Chretin, J. D. (2019, January 1). Journal of the American Animal Hospital Association, Vol. 55, pp. 101–109.

Lymphoma, Rescue Therapy

In E. Cote (Ed.), Clinical Veterinary Advisor: Dogs and Cats (4th ed.). Elsevier.

Perianal

In E. Cote (Ed.), Clinical Veterinary Advisor: Dogs and Cats (4th ed.).

Prognostic and predictive significance of KIT protein expression and c‐kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology‐Pathology Working Group

Thamm, D. H., Avery, A. C., Berlato, D., Bulman‐Fleming, J., Clifford, C. A., Hershey, A. E., … Webster, J. D. (2019, July 2). Veterinary and Comparative Oncology.

Dogs with acute myeloid leukemia or lymphoid neoplasms (large cell lymphoma or acute lymphoblastic leukemia) may have indistinguishable mediastinal masses on radiographs

Epperly, E., Hume, K. R., Moirano, S., Stokol, T., Intile, J., Erb, H. N., & Scrivani, P. V. (2018, May 3). Veterinary Radiology & Ultrasound, Vol. 59, pp. 507–515.

Tolerability of Lomustine in Combination with Cyclophosphamide in Dogs with Lymphoma

Journal of the American Animal Hospital Association, 50(3), 167–173.

A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours

Veterinary and Comparative Oncology, 8(2), 138–152.

Comparison between l-CHOP and an l-CHOP protocol with interposed treatments of CCNU and MOPP (l-CHOP-CCNU-MOPP) for lymphoma in dogs

Veterinary and Comparative Oncology, 8(4), 243–253.

Phase II, Open-Label Trial of Single-Agent CCNU in Dogs with Previously Untreated Histiocytic Sarcoma

Journal of Veterinary Internal Medicine, 24(6), 1528–1531.

Evaluation of dexamethasone as a chemoprotectant for CCNU-induced bone marrow suppression in dogs

Veterinary and Comparative Oncology, 7(1), 69–77.

Efficacy of Vinblastine for Treatment of Canine Mast Cell Tumors

Journal of Veterinary Internal Medicine, 22(6), 1390–1396.

A mechanism for combinatorial regulation of electrical activity: Potassium channel subunits capable of functioning as Src homology 3-dependent adaptors

Proceedings of the National Academy of Sciences, 98(2), 705–710.